顧みられない熱帯病(NTD)治療の世界市場2017-2027

◆英語タイトル:Global Treatment for Neglected Tropical Disease Market 2017-2027
◆商品コード:VGAIN7081119
◆発行会社(調査会社):visiongain
◆発行日:2017年9月
◆ページ数:157
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle User(1名閲覧)GBP2,499 ⇒換算¥372,351見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥446,851見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥744,851見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規販売代理店です。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
visiongain社が発行した当調査レポートでは、顧みられない熱帯病(NTD)治療の世界市場について調査・分析し、顧みられない熱帯病(NTD)治療の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
・レポートの概要
・イントロダクション
・顧みられない熱帯病(NTD)治療の世界市場
 (市場規模予測、市場動向、市場の成長要因・阻害要因など)
・顧みられない熱帯病(NTD)治療の世界市場:セグメント別市場分析
・顧みられない熱帯病(NTD)治療の世界市場:地域別市場分析、市場規模予測
・市場環境分析
・専門家の見解
・主要企業分析
・結論
【レポートの概要】

The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 157-page report you will receive 71 tables and 80 figures– all unavailable elsewhere.

The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.


• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type:
- Malaria treatments
- Dengue treatments
- Leishmaniasis
- Schistosomiasis
- Lymphatic Filariasis
- Chagas Disease
- Others

For each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.

• This report provides revenue forecast for these leading drugs:
- Coartem (Novartis)
- Clindamycin (Pfizer)
- Dengvaxia (Sanofi)
- AmBisome (Gilead Sciences)
- Impavido (Knight Therapeutics)
- ALBENZA (Amedra Pharmaceuticals LLC)

• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:
- North America: US and Canada
- Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
- Asia-Pacific: Japan, China, India, Rest of Asia
- Latin America: Brazil, Mexico, Rest of Latin America
- Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & Africa

Each regional market is further broken down by disease type.

• This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:
- Pfizer, Inc.
- Bayer
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis International AG
- Takeda Pharmaceutical Company Ltd
- Sanofi S.A.
- Eisai Co., Ltd

【レポートの目次】

1. Report Overview
1.1 Global Treatment for Neglected Tropical Disease Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Treatment for Neglected Tropical Disease Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. Introduction to Treatment for Neglected Tropical Disease
2.1 An Introduction to Treatment for Neglected Tropical Disease
2.2. Malaria Treatments
2.3. Dengue Treatments
2.4. Leishmaniasis
2.5 Schistosomiasis
2.6 Lymphatic Filariasis
2.7 Chagas Disease
2.8. Drivers
2.8.1. Increasing prevalence of various neglected tropical disease
2.8.2. Product Launch and Government Initiatives
2.9. Restrains
2.9.1 High Possibilities of Side Effect of Vaccine

3. Global Treatment for Neglected Tropical Disease Market 2017-2027
3.1 Global Treatment for Neglected Tropical Disease Market Forecast 2017-2027
3.2 Changing Market Shares by Segment2017-2027
3.3 Global Malaria Treatments Segment Market: Sales Forecast 2017-2027
3.3.1. Leading Drugs in the Malaria Treatments Market
3.3.1.1. Coartem (Novartis)
3.3.1.2. Clindamycin (Pfizer, Inc.)
3.3.1.3. Other Malaria Drugs
3.3.2. SWOT Analysis of the Malaria Treatments Market, 2017-2027
3.3.2.1. Strength
3.3.2.1.1. Supportive Government policy for Primary Health Care strategies
3.3.2.2. Weakness
3.3.2.2.1. Inadequacies in public health infrastructure, including training facilities
3.3.2.3. Opportunity
3.3.2.3.1. Increasing prevalence of Malaria
3.3.2.4. Threat
3.3.2.4.1. Community resistance to surveillance activities
3.4 Global Dengue treatments Segment Market: Sales Forecast 2017-2027
3.4.1. Dengvaxia (Sanofi)
3.4.2. SWOT Analysis of the Dengue Treatments Market, 2017-2027
3.4.2.1. Strength
3.4.2.1.1. Approval of Dengvaxia
3.4.2.2. Weakness
3.3.2.2.1. Vaccine is not available worldwide
3.4.2.3. Opportunity
3.4.2.3.1. Increasing prevalence of Dengue
3.4.2.4. Threat
3.4.2.4.1. Side Effects of Dengvaxia
3.5 Global Leishmaniasis Segment Market: Sales Forecast 2017-2027
3.5.1. AmBisome (Gilead Sciences)
3.5.2. Impavido (Marketed by Knight Therapeutics)
3.5.3. Leishmaniasis Drugs
3.5.4. SWOT Analysis of the Leishmaniasis Market, 2017-2027
3.5.4.1. Strength
3.5.4.1.1. Availability of vaccines
3.5.4.2. Weakness
3.5.4.2.1. No or less prevalence in developed regions
3.5.4.3. Opportunity
3.5.4.3.1. Increasing Prevalence of Visceral leishmaniasis
3.5.4.4. Threat
3.5.4.4.1. Patient don’t know if they are infected
3.6 Global Schistosomiasis Segment Market: Sales Forecast 2017-2027
3.6.1. SWOT Analysis of the Schistosomiasis Market, 2017-2027
3.6.1.1. Strength
3.6.1.1.1. Increasing prevalence of Schistosomiasis
3.6.1.2. Weakness
3.6.1.2.1. No or less prevalence in North America and Europe
3.6.1.3. Opportunity
3.6.1.3.1. Major patient base in Middle East & Africa
3.6.1.4. Threat
3.6.1.4.1. New Entrants
3.7 Global Lymphatic Filariasis Segment Market: Sales Forecast 2017-2027
3.7.1. ALBENZA (Amedra Pharmaceuticals LLC)
3.7.2. Lymphatic Filariasis Drugs
3.7.3. SWOT Analysis of the Lymphatic Filariasis Market, 2017-2027
3.7.3.1. Strength
3.7.3.1.1. Increasing number of patient treated with lymphatic filariasis
3.7.3.2. Weakness
3.7.3.2.1. Availability of vaccine for the patients
3.7.3.3. Opportunity
3.7.3.3.1. Increasing prevalence of Lymphatic Filariasis
3.7.3.4. Threat
3.7.3.4.1. Side Effects of ALBENZA
3.8 Global Chagas Disease Segment Market: Sales Forecast 2017-2027
3.8.1. Chagas Disease Drugs
3.8.2. SWOT Analysis of the Chagas Disease Market, 2017-2027
3.8.2.1. Strength
3.8.2.1.1. Increasing prevalence rate of underdiagnosed migrants
3.8.2.2. Weakness
3.8.2.2.1. Low prevalence of Chagas Disease in Asia-Pacific and Middle East & Africa
3.8.2.3. Opportunity
3.8.2.3.1. Increasing prevalence of Chagas Disease
3.8.2.4. Threat
3.8.2.4.1. Neglected by market players
3.9 Global Others Segment Market: Sales Forecast 2017-2027

4.Leading National Markets 2017-2027
4.1 Geographical Breakdown of the World Treatment for Neglected Tropical Disease Market
4.2 World Treatment for Neglected Tropical Disease Market: Regional Forecast 2017-2027
4.2.1 How Will Regional Market Shares Change to 2027?

5. North America Treatment for Neglected Tropical Disease Market 2017-2027
5.1. U.S. Treatment for Neglected Tropical Disease Market: Trends and Developments
5.2. Canada Treatment for Neglected Tropical Disease Market: Trends and Developments

6. Europe Treatment for Neglected Tropical Disease Market 2017-2027
6.1. Germany Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.2. France Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.3. U.K. Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.4. Italy Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.5. Spain Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.6. Rest of Europe Treatment for Neglected Tropical Disease Market Forecast 2017-2027

7. Asia-Pacific Treatment for Neglected Tropical Disease Market 2017-2027
7.1. China Treatment for Neglected Tropical Disease Market: Trends and Developments
7.2. Japan Treatment for Neglected Tropical Disease Market: Trends and Developments
7.3. India Treatment for Neglected Tropical Disease Market: Trends and Developments
7.4. Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market: Trends and Developments

8. Latin America Treatment for Neglected Tropical Disease Market 2017-2027
8.1 Brazil Treatment for Neglected Tropical Disease Market: Trends and Developments
8.2. Mexico Treatment for Neglected Tropical Disease Market: Trends and Developments
8.3. Rest of Latin America Treatment for Neglected Tropical Disease Market: Trends and Developments

9. Middle East and Africa Treatment for Neglected Tropical Disease Market 2017-2027
9.1. Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast 2017-2027
9.2. South Africa Treatment for Neglected Tropical Disease Market Forecast 2017-2027
9.3. Rest of Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast 2017-2027

10. Leading Companies in the Treatment for Neglected Tropical Disease Market
10.1. Pfizer, Inc.
10.1.1 Pfizer, Inc.: Treatment for Neglected Tropical Disease Product Portfolio
10.1.2 Pfizer, Inc.: Financial Overview
10.1.3 Pfizer, Inc.: Recent Developments
10.2. Bayer AG
10.2.1 Bayer AG: Treatment for Neglected Tropical Disease Portfolio
10.2.2 Bayer AG: Financial Overview
10.2.3 Bayer AG: Recent Transactions Summary
10.3. GlaxoSmithKline plc
10.3.1 GlaxoSmithKline plc: Treatment for Neglected Tropical Disease Portfolio
10.3.2 GlaxoSmithKline plc: Financial Overview
10.3.3 GlaxoSmithKline plc: Recent Transactions Summary
10.4. Merck & Co., Inc.
10.4.1 Merck & Co., Inc.: Treatment for Neglected Tropical Disease Portfolio
10.4.2 Merck & Co., Inc.: Financial Overview
10.4.3 Merck & Co., Inc.: Recent Transactions Summary
10.5. Novartis AG
10.5.1 Novartis: Treatment for Neglected Tropical Disease Product Portfolio
10.5.2 Novartis: Financial Overview
10.5.3 Novartis: Recent Developments
10.6. Takeda Pharmaceutical Company Ltd
10.6.1 Takeda Pharmaceutical Company Ltd: Treatment for Neglected Tropical Disease Product Portfolio
10.6.2 Takeda Pharmaceutical Company Ltd: Financial Overview
10.6.3 Takeda Pharmaceutical Company Ltd: Recent Developments
10.7. Sanofi S.A.
10.7.1 Sanofi S.A.: Treatment for Neglected Tropical Disease Product Portfolio
10.7.2 Sanofi S.A.: Financial Overview
10.7.3 Sanofi S.A.: Recent Developments
10.8. Eisai Co., Ltd
10.8.1 Eisai Co., Ltd: Treatment for Neglected Tropical Disease Product Portfolio
10.8.2 Eisai Co., Ltd: Financial Overview
10.8.3 Eisai Co., Ltd: Recent Developments

11. Conclusions
11.1 The World Treatment for Neglected Tropical Disease Market in 2016 and 2016
11.1.1 Current Leading Treatment for Neglected Tropical Disease Segments
11.1.2 Leading Regional Markets
11.2 World Treatment for Neglected Tropical Disease Market Forecast 2017-2027
11.3 The Future of the Treatment for Neglected Tropical Disease Market?

List of Tables
Table 3.1 Global Treatment for Neglected Tropical Disease Market by Diseases Types: Revenue ($m) and Market Share (%), 2016
Table 3.2 Global Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.3 Global Malaria Treatments Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.4 Global Coartem Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.5 Global Clindamycin Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.6 Other Malaria Drugs
Table 3.7 SWOT Analysis of the Malria Market, 2017-2027
Table 3.8 Global Dengue Treatments Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.9 Global Dengvaxia Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.10 SWOT Analysis of the Dengue Treatment Market, 2017-2027
Table 3.11 Global Leishmaniasis Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.12 Global AmBisome Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.13 Global Impavido Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.14 Other Leishmaniasis Drugs
Table 3.15 SWOT Analysis of the Leishmaniasis Market, 2017-2027
Table 3.16 Global Schistosomiasis Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.17 SWOT Analysis of the Schistosomiasis Market, 2017-2027
Table 3.18 Global Lymphatic Filariasis Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.19 Global ALBENZA Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.20 Other Lymphatic Filariasis Drugs
Table 3.21 SWOT Analysis of the Lymphatic Filariasis Market, 2017-2027
Table 3.22 Global Chagas Disease Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.23 Other Chagas Disease Drugs
Table 3.24 SWOT Analysis of the Chagas Disease Market, 2017-2027
Table 3.25 Global Others Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.1 Global Treatment for Neglected Tropical Disease Market by Region: Revenue ($m), 2016 and 2017
Table 4.2 Global Treatment for Neglected Tropical Disease Market Forecast, by Region: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 5.1 North America Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 5.2 North America Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
Table 5.3 U.S. Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 5.4 Canada Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.1 Europe Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.2 Europe Treatment for Neglected Tropical Disease Market Forecast, By Country: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.3 Germany Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.4 France Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.5 U.K. Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.6 Italy Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.7 Spain Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.8 Rest of Europe Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.1 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 7.2 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
Table 7.3 China Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.4 Japan Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.5 India Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.6 Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 8.1 Latin America Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 8.2 Latin America Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
Table 8.3 Brazil Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 8.4 Mexico Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 8.5 Rest of Latin America Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 9.1 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 9.2 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast, by Country 2016-2027 ($m, AGR %, CAGR %)
Table 9.3 Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 9.4 South Africa Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 9.5 Rest of MEA Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 10.1 Pfizer, Inc.: Overview, 2017
Table 10.2 Pfizer, Inc.: Revenue ($m), AGR (%), 2012-2016
Table 10.3 Bayer AG: Overview, 2017
Table 10.4 Bayer AG: Revenue ($m), AGR (%), 2012-2016
Table 10.5 GlaxoSmithKline plc: Overview, 2017
Table 10.6 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2012-2016
Table 10.7 Merck & Co., Inc.: Overview, 2017
Table 10.8 Merck & Co., Inc.: Revenue ($m), AGR (%), 2012-2016
Table 10.9 Novartis: Overview, 2017
Table 10.10 Novartis: Revenue ($m), AGR (%), 2012-2016
Table 10.11 Takeda Pharmaceutical Company Ltd: Overview, 2017
Table 10.12 Takeda Pharmaceutical Company Ltd: Revenue ($m), AGR (%), 2012-2016
Table 10.13 Sanofi S.A.: Overview, 2017
Table 10.14 Sanofi S.A.: Revenue ($m), AGR (%), 2012-2016
Table 10.15 Eisai Co., Ltd: Overview, 2017
Table 10.16 Eisai Co., Ltd: Revenue ($m), AGR (%), 2011-2015

List of Figure
Figure 1.1 Global Treatment for Neglected Tropical Disease Market Segmentation Overview
Figure 3.1 Global Treatment for Neglected Tropical Disease Market by Diseases Type: Market Share (%), 2016
Figure 3.2 Global Treatment for Neglected Tropical Disease Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.3 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2016
Figure 3.4 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2021
Figure 3.5 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2027
Figure 3.6 Global Malaria Treatments Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.7 Global Coartem Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.8 Global Clindamycin Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.9 Global Dengue Treatments Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.10 Global Dengvaxia Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.11 Global Leishmaniasis Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.12 Global AmBisome Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.13 Global Impavido Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.14 Global Schistosomiasis Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.15 Global Lymphatic Filariasis Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.16 Global ALBENZA Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.17 Global Chagas Disease Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.18 Global Others Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 4.1 World Treatment for Neglected Tropical Disease Market: Revenues ($m) by Region, 2016
Figure 4.2 World Treatment for Neglected Tropical Disease Market: Revenues ($m) by Region, 2017
Figure 4.3 Global Treatment for Neglected Tropical Disease Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 4.4 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2016
Figure 4.5 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2021
Figure 4.6 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2027
Figure 5.1 North America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 5.2 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 5.3 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 5.4 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 5.5 US Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 5.6 Canada Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.1 Europe Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.2 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 6.3 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 6.4 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 6.5 Germany Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.6 France Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.7 U.K. Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.8 Italy Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.9 Spain Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.10 Rest of Europe Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.1 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.2 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 7.3 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 7.4 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 7.5 China Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.6 Japan Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.7 India Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.8 Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 8.1 Latin America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 8.2 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 8.3 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 8.4 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 8.5 Brazil Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 8.6 Mexico Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 8.7 Rest of Latin America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 9.1 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 9.2 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 9.3 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 9.4 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 9.5 Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 9.6 South Africa Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 9.7 Rest of MEA Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 10.1 Pfizer, Inc.: Revenue ($m), AGR (%), 2012-2016
Figure 10.2 Pfizer, Inc.: National Revenue Share (%), 2016
Figure 10.3 Bayer AG: Revenue ($m), AGR (%), 2012-2016
Figure 10.4 Bayer AG: Business Segment Revenue Share (%), 2016
Figure 10.5 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2012-2016
Figure 10.6 GlaxoSmithKline plc: Business Segment Revenue Share (%), 2016
Figure 10.7 Merck & Co., Inc.: Revenue ($m), AGR (%), 2012-2016
Figure 10.8 Merck & Co., Inc.: Business Segment Revenue Share (%), 2016
Figure 10.9 Novartis: Revenue ($m), AGR (%), 2012-2016
Figure 10.10 Novartis: Revenue, by Region, Share (%), 2016
Figure 10.11 Takeda Pharmaceutical Company Ltd: Revenue ($m), AGR (%), 2012-2016
Figure 10.12 Takeda Pharmaceutical Company Ltd: Revenue, by Region, Share (%), 2016
Figure 10.13 Sanofi S.A.: Revenue ($m), AGR (%), 2012-2016
Figure 10.14 Sanofi S.A.: Revenue, by Region, Share (%), 2016
Figure 10.15 Eisai Co., Ltd: Revenue ($m), AGR (%), 2011-2015
Figure 11.1 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2016
Figure 11.2 Treatment for Neglected Tropical Disease Market, By Region Share (%), 2016, 2021, 2027

【レポートのキーワード】

顧みられない熱帯病(NTD)、顧みられない熱帯病治療

★調査レポート[顧みられない熱帯病(NTD)治療の世界市場2017-2027] (コード:VGAIN7081119)販売に関する免責事項を必ずご確認ください。
★調査レポート[顧みられない熱帯病(NTD)治療の世界市場2017-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆